Annual Total Expenses
$68.35 M
+$38.02 M+125.36%
31 December 2023
Summary:
Verrica Pharmaceuticals annual total expenses is currently $68.35 million, with the most recent change of +$38.02 million (+125.36%) on 31 December 2023. During the last 3 years, it has risen by +$28.16 million (+70.10%). VRCA annual total expenses is now at all-time high.VRCA Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$18.92 M
-$1.46 M-7.16%
30 September 2024
Summary:
Verrica Pharmaceuticals quarterly total expenses is currently $18.92 million, with the most recent change of -$1.46 million (-7.16%) on 30 September 2024. Over the past year, it has dropped by -$7.91 million (-29.48%). VRCA quarterly total expenses is now -29.48% below its all-time high of $26.83 million, reached on 30 September 2023.VRCA Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRCA Total Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +125.4% | -29.5% |
3 y3 years | +70.1% | +60.8% |
5 y5 years | +212.4% | +189.2% |
VRCA Total Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +125.4% | -29.5% | +201.4% |
5 y | 5 years | at high | +212.4% | -29.5% | +201.4% |
alltime | all time | at high | +3472.7% | -29.5% | +3219.8% |
Verrica Pharmaceuticals Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $18.92 M(-7.2%) |
June 2024 | - | $20.38 M(-9.1%) |
Mar 2024 | - | $22.43 M(-0.7%) |
Dec 2023 | $68.35 M(+125.4%) | $22.59 M(-15.8%) |
Sept 2023 | - | $26.83 M(+127.4%) |
June 2023 | - | $11.80 M(+65.6%) |
Mar 2023 | - | $7.13 M(+13.5%) |
Dec 2022 | $30.33 M(-29.3%) | $6.28 M(-8.6%) |
Sept 2022 | - | $6.87 M(-26.4%) |
June 2022 | - | $9.34 M(+19.1%) |
Mar 2022 | - | $7.84 M(-7.4%) |
Dec 2021 | $42.91 M(+6.8%) | $8.47 M(-28.0%) |
Sept 2021 | - | $11.77 M(+9.7%) |
June 2021 | - | $10.73 M(-10.1%) |
Mar 2021 | - | $11.94 M(-0.8%) |
Dec 2020 | $40.18 M | $12.03 M(+24.9%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2020 | - | $9.64 M(+11.7%) |
June 2020 | - | $8.63 M(-12.6%) |
Mar 2020 | - | $9.88 M(+23.7%) |
Dec 2019 | $30.08 M(+37.5%) | $7.99 M(+22.1%) |
Sept 2019 | - | $6.54 M(-13.0%) |
June 2019 | - | $7.52 M(-6.3%) |
Mar 2019 | - | $8.03 M(-2.0%) |
Dec 2018 | $21.88 M(+390.9%) | $8.19 M(+29.3%) |
Sept 2018 | - | $6.33 M(+15.8%) |
June 2018 | - | $5.47 M(+189.7%) |
Mar 2018 | - | $1.89 M(+31.7%) |
Dec 2017 | $4.46 M(+133.0%) | $1.43 M(+5.6%) |
Sept 2017 | - | $1.36 M(+24.0%) |
June 2017 | - | $1.09 M(+92.1%) |
Mar 2017 | - | $570.00 K |
Dec 2016 | $1.91 M | - |
FAQ
- What is Verrica Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals annual total expenses year-on-year change?
- What is Verrica Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals quarterly total expenses year-on-year change?
What is Verrica Pharmaceuticals annual total expenses?
The current annual total expenses of VRCA is $68.35 M
What is the all time high annual total expenses for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high annual total expenses is $68.35 M
What is Verrica Pharmaceuticals annual total expenses year-on-year change?
Over the past year, VRCA annual total expenses has changed by +$38.02 M (+125.36%)
What is Verrica Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of VRCA is $18.92 M
What is the all time high quarterly total expenses for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high quarterly total expenses is $26.83 M
What is Verrica Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, VRCA quarterly total expenses has changed by -$7.91 M (-29.48%)